Microsoft: Spending Spree
Shares of the software giant lost 11% on Friday after the company said it would spend far more than originally anticipated to boost marketing and development of new products. So, what's the future for the stock now?
Investors have waited a long time for Microsoft to turn a corner. The stock hasn't gone anywhere since 1999 -- well, actually it peaked at $60 late that year and has been trading in a fairly narrow band in the $20s since 2003. In March, the Redmond, Washington, software colossus disappointed investors mildly when it said it would delay the release of its updated Office software and Vista, the new Windows operating system, until next year.
But investors really got angry on April 28, after Microsoft announced it would spend about $2 billion more than originally anticipated in the June 2007 fiscal year to boost marketing and development of new products. Massive selling drove the shares (symbol MSFT) down 11%, to $24, reducing Microsoft's market value by $32 billion. Chairman Bill Gates lost more than $3 billion on paper.
The company also missed analyst expectations for its March quarter. Microsoft reported that profits rose 16% in the quarter ended March 31, to $3 billion, or 29 cents a share. Sales in the quarter were up 13%, to $10.9 billion, but were less than what analysts expected. "It appears investors can't win," says Friedman Billings Ramsey analyst David Hilal. "When growth was slowing, margins were improving. Investors begged for some meaningful growth. Now we have it, but it's at the expense of profits." Hilal retains his "outperform" rating on the stock, with a price target of $32.

Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Microsoft's splurge is aimed at creating Web services that will compete with offerings from Google and Yahoo. Other initiatives include heavily promoting the XBox 360 and crafting new security and communications software. The spending spree "removes any possibility of meaningful earnings acceleration or upside for the foreseeable future," says Lehman Brothers analyst Israel Hernandez, who cut his target price for Microsoft shares from $32 to $25.
The extra expenses for new products is a bump on the long-term path of growth, says Merrill Lynch analyst Kash Rangan. "The time is right for Microsoft to make this bold strategy bet -- two years from now may be too late," he says. Hilal thinks the money spent is a trade-off for long-term gains. "The business is accelerating on the heels of a strong product cycle and double-digit growth should be sustainable for the next few years," he says.
Friday's sell-off puts the stock in valuation territory it has rarely seen before. It sells at 18 times the $1.32 per share that analysts expect the company to earn for the fiscal year ending June 30, according to Thomson First Call, and about 17 times the high end of the range that Microsoft forecasts it will earn in the June 2007 year. While that is cheap by historical standards, it's probably not cheap enough to whet the appetites of true bargain hunters. And uncertainties surrounding Microsoft's earnings prospects make it unlikely that the stock will interest growth investors. For the foreseeable future, the stock is probably dead money.
--Thomas M. Anderson
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
-
Social Security New Rule: Overpayments Must Be Paid Back 100%. Why It Matters
As of March 27, the SSA will require beneficiaries who have been accidentally overpaid to repay 100% of the money, reversing a previous policy that allowed for only 10% recoupment.
By Kathryn Pomroy Published
-
Medicare and Medicaid Employees Offered New Buyouts: What You Need to Know
Federal HHS workers who inspect food, research diseases and administer Medicare and Medicaid are offered $25,000 buyouts
By Kathryn Pomroy Published
-
Stock Market Today: Mixed Messages Muddle Markets
Stocks cruised into pre-market action on encouraging news for the AI revolution but stumbled on yet another policy disturbance.
By David Dittman Published
-
Stock Market Today: Dow Gains After Nike Gets Upgraded
Jefferies thinks Nike's new CEO will spark a turnaround in the beaten-down blue chip.
By Karee Venema Published
-
Best Investments to Sidestep Trump's Trade War
These ETFs are well-designed to weather rising U.S. protectionism and retaliatory tariffs.
By Jeff Reeves Last updated
-
How to Invest in the Nuclear Revolution
According to Energy Secretary Chris Wright, "The long-awaited American nuclear renaissance must launch during President Trump's administration."
By David Dittman Published
-
Stock Market Today: Stocks Pop on Time-Delayed Tariffs
All three major U.S. equity indexes rallied to intraday highs following President Trump's latest trade moves.
By David Dittman Published
-
Stock Market Today: Markets Turn Lower on Nasty Inflation Surprise
Equities sold off after a hot reading on consumer price inflation pushed back rate cuts to autumn or year-end.
By Dan Burrows Published
-
Stock Market Today: Stocks Swing Lower as Inflation Fears Rise
The latest consumer sentiment data showed near-term inflation expectations rose to their highest level since November 2023.
By Karee Venema Published
-
Stock Market Today: Investors Respond to the Usual Uncertainty
Stocks surged late but the major indexes closed mixed as the search for market leadership continues.
By David Dittman Published